Allied Academies invites all the participants from all over the world to attend “International Obstetricians and Gynecologists Summit” held at San Antonio, USA on November 13-14, 2017 which includes prompt Keynote Presentations, Special Sessions, Workshops, Symposiums, Oral talks, Poster Presentations and Exhibitions.
Theme: Fresh thoughts for a quality and safety care for women’s health
Obstetricians & Gynecologists 2017 offers a cutting edge program of renowned international speakers and specialists, concurrent sessions, oral and poster presentations attracting over 450 experts in fertility, assisted conception, sexual health and reproductive biology and gynecology field. This conference has been carefully designed to meet the unique educational needs of Gynecologists.
Obstetricians & Gynecologists 2017 has been made in an interdisciplinary manner with various tracks to choose from every segment and provides you a unique opportunity to meet up with peers from both industry and academia and establish a scientific network among. We cordially invite to join us at our event and make it successful by your participation.
A comprehensive range of topics will be discussed in the event including maternal fetal medicine, gynecology oncology, Sexual medicine, Substance Use & abuse, ultrasound diagnosis, Menstruation, leukoaraiosis, Endometriosis, Body Mass Index, genitourinary medicine, and Gynecologic Cancers. It is our ideology to bring maximum exposure to our attendees, so we make sure the event is a blend which covers professionals such as gynecologists, obstetricians, veteran researchers, Women healthcare professionals from academia and industry making the conference a perfect platform.
Allied Academies was founded by Jim and JoAnn Carland and the headquarters is located in North Carolina in United States of America. It conducts several academic conferences each year in different locations with internet participation possibilities for those who are physically unable to attend the conferences. Conference registrants are eligible for the Accelerated Journal Review. To provide you with maximum outlets for your research, Allied Business Academies holds joint meetings of all its member academies. In 1994 they launched the Journal of the International Academy of Case Studies, which has become a leader in publishing classroom teaching cases in business.
Why to attend???
With members from around the world focused on learning about Women’s Health and its advances, this is your best opportunity to reach the largest assemblage of participants from the Women’s Health community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new discoveries in the breast cancer treatment and diagnosis, and receive name recognition at this 2-days event. World-renowned speakers, the most recent techniques, developments, and the newest updates in women’s health, breast cancer, gynecological issues, pregnancy, Woman Psychology, women disorders are hallmarks of this conference.
Allied Academics feels proud and pleasure to invite Research Scientists, Obstetricians, Gynaecologits, Professors, Students and Healthcare Diagnostics to attend the "International Obstetricians, Gynaecologists Summit & Reproductive Biology" to be held at SAN ANTONIO, TEXAS, USA during November 13th & November 14th,2017.
Allied Academics has been instrumental in Conducting International Meetings for 20 years and very excited to expand in Medical and health Care Fields. Allied Academics promotes peer reviewed healthcare information through meetings, scholarly journals, and training to leading academic, business and research institutes across the healthcare and life science industries.
Sessions and Tracks
Gynecology & Obstetrics
Epidemiology in Obstetrics and Gynecology
Health Related Behaviors in Women
World Market for
Gynecology, 2007-2017 provides a unique assessment of current developments and
prospective factors that will shape the global female health market over the
next decade. This unrivalled, in-depth market research study commissioned by
one of the top three multinational pharmaceutical companies presents a detailed
and comprehensive analysis of prescription products used in the diverse areas
of infertility, contraception, gynecological disorders, and menopause.
The market for gynecology is predicated on hormonal drugs that have recently been subject to controversy based on reports of associated increased risks of cardiovascular disease and cancer. The global market has suffered as a consequence due to cautious prescribing approaches for hormone replacement therapies. The market for gynecology is showing signs of a significant upward growth trend over the forecast period to 2017 and the next decade will be exciting, but companies will need to differentiate their products and consider the market forces that may affect product revenue and portfolios.
The World Market for Gynecology aims to provide an expert analysis of the prescription drug market for female health over the next decade based on current industrial insights, market factors and forces, and trend information. Study objectives include critical assessments of existing products, reviews of products in clinical development, therapy forecasting of product/portfolios to 2017, and market sector analytics by therapeutic category and discrete disorder.
The laparoscopic instruments market is projected to reach USD 11.68 Billion by 2021, growing at a CAGR of 8.9% during the forecast period of 2016 to 2021. Growth in the laparoscopic instruments market can be attributed to factors such as increasing investments in the laparoscopic instruments market, growing patient and physician preference for laparoscopic procedures as compared to open surgeries, rise in geriatric population, rise in prevalence of colorectal cancer and obesity which can be treated laparoscopically, and technological advances in the field of laparoscopic instruments. In the coming years, the laparoscopic instruments market is expected to witness the highest growth rate in the Asia-Pacific region. North America is expected to account for the largest share of the global laparoscopic instruments market in 2016. However, reduced Medicare payments to healthcare providers in the U.S., competition offered by robotic minimally invasive surgeries as an alternative to laparoscopic procedures, and dearth of trained physicians are likely to restrain the growth of the market during the forecast period.
The medical image analysis software market is expected to reach USD 3,135.3 Million by 2020 from USD 2,143.7 Million in 2015, at a CAGR of 7.9% from 2015 to 2020. Major factors driving the growth of this market include technological advancements, growing public- and private-sector investments, rapid growth in aging population, fusion of imaging technologies, growing applications of computer-aided diagnosis (CAD), rising incidences of chronic diseases, and increasing usage of imaging equipment. On the other hand, financial constraints, growing hacking-related risks associated with the use of medical equipment and software, and dearth of skilled professionals are the major factors restraining the growth of this market.
The global ultrasound market is expected to reach USD 6.86 Billion by 2020 from USD 5.25 Billion in 2015, at a CAGR of 5.5% from 2015 to 2020. Market growth can be attributed to the rising patient population base for chronic and lifestyle-related disorders (such as hypertension and vascular disorders) coupled with growing geriatric population; technological advancements; increasing public-private investments, funds, and grants; and growing market demand for minimally invasive disease diagnosis and treatment.
North America dominated the global market with a revenue share of 40.6% in 2014. High adoption rate of advanced technology and the presence of large market players in the region are some factors accounting for its large revenue share. The region is expected to maintain its dominance throughout the forecast period, mainly due to the growth in the number of new detected cases.
Government and healthcare agencies in North America are promoting routine check-ups to lower mortality rates associated with breast and cervical cancer patients since, early detection increases treatment success rates.
Asia Pacific is anticipated to witness lucrative growth during the forecast period. Growth in the inflow of patients owing to the rapidly booming medical tourism industry is expected to serve as the highest impact rendering driver.
Moreover, the presence of a large pool of skilled professionals, cheaper labor cost, and advance manufacturing facilities have resulted in the shifting of manufacturing facilities to China and India. As a result, the overall manufacturing costs of these devices have reduced. Therefore, manufacturers are now able to offer their products at lower cost.
IMPORTANCE AND SCOPE:
Obstetrics deals with the care of pregnant women and the unborn child. Gynecology deals with the management of diseases that are specific to women. Many new techniques and procedures have been developed over years and improved the health of women and babies. The ultrasound devices have improved the care of the baby in the womb. It has been evolving in both molecular and clinical level with many researches. The research in Obstetrics and Gynecology lead to the discovery of maternal and fetal medicine, reproductive medicine, urogynaecology, gynecological oncology and reproductive health care.
SCOPE OF THE REPORT:
Commissioned by a market leader in Women’s and Sexual Health, this report uniquely provides a comprehensive analysis of current and pipeline gynecology products, which is not available elsewhere in the market literature; Provides a concise overview of the conditions and diseases related to gynecology including aetiology, epidemiology, and management; Complete description of existing products to include reviews of product characteristics, side effects, and sales performance; Extensive information on new gynecological drugs in the pipeline, including product characteristics, technologies, research status, and the results of clinical trials; Market analysis of the US and international markets for gynecological prescription products with therapy area and sales forecasts to 2017; Analysis of market dynamics for infertility, contraception, menstrual and gynecological disorders, and menopause; Product-focused appraisals and discussions for market potential and growth; Benchmark analytics for current research themes and future therapy areas; Evaluation of the key drivers and predictors of growth and innovation in gynecology; In-depth assessment of the commercial and drug development opportunities in the field. Reports on the status of existing and pipeline gynecology prescription products to 2017; Highlights the drug development strategies that are being employed by companies to sustain leadership; Provides a comprehensive description of gynecological and obstetric drugs currently on the market; Describes the pipelines and biological targets being pursued by a host of companies, both small and large; Assists in analyzing discovery programs of competitors and aids decision-making for in-house research and development; Provides critical information on how companies are reformulating hormonal drugs to solve market, clinical, and regulatory barriers; Provides market trend data of best- and least-performing gynecology products; Identifies niche markets where there is an unmet need for gynecological and obstetric therapeutics; Provides forecasts of products, therapy areas, and drug classes to 2017; Shows estimation of the global market for gynecology to include both hormonal and non-hormonal products.